Sionna Therapeutics SION
Sionna Therapeutics: annual report for the year ended Dec 31, 2024
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0002036042-25-000005
- Document
- 10-K
- Exhibit 4.3
- Warrants or notes
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Emergent BioSolutions EBS public float $343M, Jun 30, 2025
- Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
- Amarin AMRN public float $335M, Jun 30, 2025
- Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
- Usana Health Sciences USNA public float $328M, Jun 27, 2025
